Media coverage about Mindray Medical International (NYSE:MR) has been trending positive this week, according to Accern Sentiment. The research group ranks the sentiment of news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Mindray Medical International earned a media sentiment score of 0.28 on Accern’s scale. Accern also gave press coverage about the medical instruments supplier an impact score of 45.3040721053939 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Mindray Medical International (MR) remained flat at $27.94 during trading on Friday. Mindray Medical International has a 1-year low of $21.80 and a 1-year high of $33.83. The stock’s 50 day moving average price is $27.20 and its 200 day moving average price is $25.81.
ILLEGAL ACTIVITY NOTICE: This news story was originally posted by Rincon Hill News and is the property of of Rincon Hill News. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international copyright laws. The correct version of this news story can be viewed at https://rinconhillneighbors.org/2017/08/19/mindray-medical-international-mr-given-media-impact-rating-of-0-28-updated.html.
About Mindray Medical International
Mindray Medical International Limited is a developer, manufacturer and marketer of medical devices across the world. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. Its patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature.
Receive News & Ratings for Mindray Medical International Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mindray Medical International Ltd and related companies with our FREE daily email newsletter.